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Background: neoangiogenesis and the immune response 
are important mechanisms in metastasis development. Aim: 
to evaluate lymph node reactivity and microvessel density in 
neck metastasis of occult primary squamous cell carcinoma 
considering their histological and clinical variables. Study 
design: retrospesctive case-series. Method: 19 patients with 
neck metastasis of occult primary squamous cell carcinoma 
who underwent neck dissection between 1983 and 2000 were 
selected. The lymph nodes were reevaluated on the type of 
reactivity in both the cortical and paracortical areas, and the 
metastasis were assessed as to grade, desmoplasia, necrosis 
and microvessel density (CD34). The relationship between 
histological and clinical variables was evaluated. Results: 
the median microvessel density was 91 vessels/mm2, varying 
from 28 to 145. Paracortical hyperplasia was more common 
in patients below 55 years of age (90% x 44%, p= 0.05), but 
there was no relationship between reactivity patterns and 
microvessel density with prognosis. The disease-free survival 
was 52% in 3 years, being similar in both groups, with higher 
or lower microvessel densities. Conclusion: microvessel 
density in neck metastasis of occult primary squamous cell 
carcinoma had a great individual variability. It wasn’t possible 
to establish the relationship between microvessel density and 
the clinical or histological variables studied.
Keywords: squamous cell cancer, lymph nodes, head and 
neck neoplasms, unknown primary neoplasms, pathologic 
neovascularization.
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INTRODUCTION
Neoangiogenesis is an important process for the 
development of tumors and is related with metastasiza-
tion and the prognosis in different types of malignant 
neoplasms1-4. The immune response, as well as anti-tu-
mor action, is part of the modulation of angiogenesis and 
other related mechanisms to the invasion and growth of 
the neoplasms. Regional lymph nodes frequently present 
signs of reactivity, the meaning of which is still unknown5,6. 
This study aims to evaluate microvascular density and 
linfonodal reactivity in cervical metastases of occult pri-
mary tumors, relating these findings to other histological 
and clinical variables, considering that this disease is an 
adequate clinical model for the study of metastases.
METHODS
All patients that had tissue samples available for 
analysis and follow-up of at least 12 months following 
initial treatment were included totalling 19 cases. Of these 
16 patients were male and 3 were female. The average 
age was 55 years. Smoking and alcohol abuse were pres-
ent in 16 and 13 cases respectively. Patients were staged 
according to the TNM 2002 classification (UICC-AJCC); 1 
patient was stage N1, 8 patients were stage N2, and 10 
patients were stage N3. The average number of nodes 
removed during radical neck dissection was 22.4 lymph 
nodes, varying from 4 to 49. Reactivity was evaluated in 
427 lymph nodes and microvascular density was assessed 
in 60 lymph nodes with metastases. Conventional histo-
logical analysis evaluated the degree of differentiation, the 
presence of tumor necrosis, desmoplasia and lymph node 
reactivity. Lymph node assessment used Berlinger et al.`s 
and Klimek et al.`s criteria, as follows5,7: 
A - Paracortical hyperplasia: increased paracortical 
celularity.
B - Follicular hyperplasia: increased number and 
size of lymphoid follicles in the lymph node cortical zone, 
formation of secondary follicles with prominent germina-
tive centers.
C - Sinus hyperplasia: endothelial cell hyperplasia 
with medullary sinusoidal distension and histiocitosis.
D - Non-stimulated lymph node: lymph nodes with 
no lymphocyte proliferation.
E - Depleted lymph node: decreased lymphocyte 
population and diffuse fibrose in lymph nodes. 
Reactivity was classified according to Amar et al., 
evaluating cortical and paracortical lymph node zones, 
taking into account the pattern in more than 2/3 of reac-
tive lymph nodes. With no predominance, hyperplasia was 
considered as mixed. Lack of reactivity in more than 80% 
of lymph nodes defined the non-reactive pattern. Sinusal 
hyperplasia and histiocitosis were assessed separately. 
Histiocitosis was defined as the presence of macrophages 
in sinusoids, characterized by large nuclei, evident nucleoli 
and eosinophilic cytoplasm. Conventional histological 
analysis included the degree of differentiation, the pres-
ence of tumor necrosis and desmoplasia. Immunohisto-
chemical reactions were made in the following order:
1. Primary antibody (Monoclonal Mouse Anti-Hu-
man CD34 Class II, Dako, M7165, Denmark) diluted at 
1:100 in PBS, for 18 hours at 4°C in a humid chamber. 
2 Secondary antibody (Biotinylated Goat Anti-
Mouse/Rabbit Ig, of the StreptAB Complex/HRP Duet 
Mouse/Rabbit, Dako, K492, Denmark) diluted at 1:200, 
for 30 minutes at 37°C. 
3 Reagent complex A (Streptavidin) and reagent B 
(Biotinylated Peroxydase) diluted at 1:200, for 30 minutes 
at 37°C.
4 Solution of 3,3’-Diaminobenzidine Tetrahydro-
chloride 60 mg% (Sigma, D5637, USA), 1 mL of Dimeth-
ylsulphoxide (DMSO), 1mL of 100 H2O2 at 6% and mL of 
PBS, for 5 minutes at 37°C, in the dark.
Microvessel counting was done under optic mi-
croscopy in 5 areas of greater intra-tumor vascular density 
(hot spots). A 0,4 mm2 area in each hot spot was selected 
using the image analysis program Image Tool 2.0 (Uni-
versity of Texas Health Science Center, USA); the number 
of microvessels were counted at 100x magnification and 
the values obtained in the 5 areas (2 mm2) were added. 
The relation between lymph node reactivity and meta-
static microvascular density, the degree of differentiation, 
desmoplasia, necrosis, clinical findings and progression 
of patients were assessed.
The Kaplan-Meier actuarial survival method was 
used for statistical analysis of and the differences between 
the groups were assessed using Gehan`s test. For quantita-
tive variables, Mann-Whitney`s U test and the Kruskal-Wal-
lis test were used to assess differences between the groups. 
Correlation between quantitative variable was done with 
Spearman`s test. For qualitative variables, Fisher`s exact 
test and the difference between two variables test were 
used, taking into account bicaudal values for p. Calculation 
was done with the software Statistica 5.1 (Statsoft Incorpo-
ration, USA) and differences in all tests were considered 
significant when p-values were equal or below 0.05.
RESULTS
Reactivity was assessed in 427 lymph nodes, of 
which 102 presented paracortical hyperplasia and 122, 
follicular hyperplasia. Sinusal hyperplasia was observed 
in 93 lymph nodes from 15 patients, which also presented 
sinusal histiocitosis. Paracortical hyperplasia, including its 
presence mixed pattern cases, was seen in 90% of patients 
below age 55 and in 44% of patients aged 55 and above 
(p=0.05).
Average microvascular density was 91.5 microves-
sels/mm2, varying from 28 to 145. Considering indepen-
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dently the degree of differentiation in each lymph node and 
the respective microvascular density, well differentiated or 
moderately differentiated tumors had a mean 55 microves-
sels/mm2 (Q25-75% = 38-90), whereas undifferentiated 
tumors had a mean 53 microvessels/mm2 (Q25-75% = 
43-116), p=0.85.
On follow-up, primary tumors was diagnosed in 3 
patients, neck recurrences were diagnosed in 10 patients 
and 4 cases had metastases at a distance. In total, 5 patients 
received salvage treatment, of which 4 underwent surgery 
and 1 was treated with radiotherapy. The remaining pa-
tients received palliative treatment. Of patients undergoing 
salvage treatment, 3 patients had the disease controlled in 
the second treatment.
The mean microvascular density in cases that had 
metastases at a distance was 73 microvessels/mm2 (Q25-
75% = 55-108) and the mean microvascular density in 
cases that did not have metastases at a distance was 99 
microvessels/mm2 (Q25-75% = 28-145), p=0.59.
The disease-free survival for the whole group was 
52% in 2 years and 44% in 5 years. Asymptomatic patients 
had an average 61 months follow-up time.
No significant relation was observed between the 
age of patients and microvascular density of metastases.
DISCUSSION
The first issue in cases of cervical metastases from 
occult primary tumors pertains to the origin of the tumor. 
Patients with occult primary tumors have similar epide-
miological characteristics compared to patients with upper 
digestive tract and upper airway primary tumors. Further-
Figure 1. Microvascular density in metastases in relation to the pattern 
of lymph node reactivity.
legend: DMV = microvascular density. Max = maximum. Min = 
minimum. 75% = 75% quartile. 25% = 25% quartile. Kruskal-Wallis 
test, p=0.27.
Figure 2. Disease-free survival according to microvascular density in 
metastases.
legend: Actuarial survival Kaplan-Meier method. Gehan`s test, 
p=0.64
more, similar genetic alterations were found in so called 
normal oral cavities and in lymph node metastases in some 
cases of occult primary tumors that, when analyzed within 
the context of field cancerization and clonal expansion, 
are strong evidence supporting the hypothesis of their 
origin in the upper digestive tract and the upper airway 
epithelium, with possible regression or tumor dormancy 
in the primary site8-10. Many studies report the association 
between microvascular density in primary tumors and 
metastases3,4.
As neoangiogenesis is an important feature for the 
Figure 3. Disease-free survival according to the pattern of lymph node 
reactivity.
legend: Actuarial survival, Kaplan-Meier method. Gehan`s test, p = 
0.35.
385
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 72 (3) MAY/JUNE 2006
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Table 1. Microvascular density according to clinical characteristics 
and histological variables.
Microvascular Density
Median Q25-75% Mim Max p
Age
≤ 55 102 (49-122) 28 145
0,82
> 55 86 (63-110) 51 133
N Stage
N1-2 62 (55-99) 47 145
0,20
N3 108 (86-122) 28 143
Reactivity
Paracortical 122 (47-143) 28 145
0,27
Mixed 102 (53-116) 41 119
Reactivity
Follicular 63 (62-86) 59 91
0,64≤ 50% 91 (49-106) 28 145
> 50% 86 (62-119) 51 143
Evolution
Sick 88 (62-119) 28 145
0,86
Asymptomatic 99 (53-110) 47 143
Necrosis
No 86 (53-116) 47 143
0,52
Yes 102 (84-113) 28 145
Desmo-
plasia
No 63 (51-116) 28 122
0,22
Yes 102 (84-133) 47 145
growth of metastases, increased angiogenesis suggests an 
advantage acquired due to clonal selection. An inverse 
relation was reported between microvascular density in 
the primary tumor and its respective metastases, suggest-
ing that increased angiogenesis in a specific site might 
inhibite angiogenesis at a distance11,12. The hypothesis 
that metastases from occult primary tumors could inhibit 
the growth of the primary tumor could be supported by 
increased microvascular density, however we found great 
variability in our study. This variability does not eliminate 
the hypothesis that systemic control of neoangiogenesis 
is implied in the etiogeny of the occult primary tumor, 
although this may not be the only mechanism involved. 
A further important issue is the meaning of tumor 
microvascular density, particularly when using the hot spot 
count technique3,13. The tumor may grow along existing 
microvessels or remodel the stroma, promoting neoangio-
genesis; however, increased microvascular density does 
not mean that the tumor has an increased blood supply. 
Necrotic tumors may have increased neoangiogenesis, 
possibly caused by an increased inflammatory response 
in this type of cell death14. In order to have diffusion of 
oxygen and nutrients, cells may be up to 110 mm from 
blood microvessels, a measure that is reached with low 
microvascular density13. Lymph nodes have a high micro-
vascular density, surpassing density observed in metasta-
ses; thus the change in blood flow caused by the growth 
of metastases also reinforces the idea that tumors modify 
the vascular structure and the dynamics of flow15,16. Un-
fortunately, the technique we used does not allow us to 
separate neoformed from existing microvessels.
There was no correlation between age and mi-
crovascular density, however, paracortical reactivity was 
found in greater frequency among patients aged below 55 
years. As decreased angiogenesis is expected with aging, 
this finding suggests that neoangiogenesis in metastases 
is related to increased inhibition17.
Lymph node reactivity, seen as paracortical or fol-
licular hyperplasia, was related to the best prognosis in 
different studies5,6,18. In various studies there was no con-
sensus on which type of reactivity has the best prognosis, 
or a method to classify heterogeneous reactivity. It is not 
uncommon to find more than one pattern in the same 
lymph node or different patterns in many lymph nodes in 
the same patient, which makes it difficult to classify these 
patients, and which might explain the variety of results. 
Most patients with occult primary tumors had reactive 
lymph nodes. The immune response is related to the re-
lease of angiogenesis promoting substances. In this study, 
cases that had paracortical reactivity had the highest mi-
crovascular densities, although not statistically significant. 
In head and neck tumors lymph nodes with follicular or 
paracortical hyperplasia are located close to the tumor, that 
is, those that habitually have metastases. Therefore, it is 
possible that the immune response favors the implantation 
and the growth of lymph node metastases.7 Furthermore, 
the immune response could be responsible for primary 
tumor regression. 
Histiocitose and sinusal hyperplasia were found 
in most patients. The latter is considered as non-specific 
reactivity and is associate with immunological dysfunction7. 
Being present in most patients, it was impossible to estab-
lish its relation with the other variables in the study. Sinusal 
hyperplasia is more frequent in lymph nodes distant from 
tumor, so we canot discard the possibility that the tumor 
Figure 4. Correlation between the age of patients and microvascular 
density of metastases.
legend: DMV = microvascular density. Spearman`s test, r2 = 0.04, 
p = 0.86.
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or the immune response in the first lymph nodes down 
the lymph channel may cause an immune supressor ef-
fect upstream of the lymphatic flow7. This hypothesis 
is reinforced by the fact that lymphocytes from lymph 
nodes in the tumor drainage area have a lower cytotoxic 
action compared to lymphocytes in peripheral blood19. 
Macrophages (histiocytes) have an important function in 
remodelling the extracellular matrix and in modulating 
angiogenesis and the immune response. Macrophages 
can also modify the genic expression and the behavior of 
tumor cells, increasing their invasive potential. This action 
could both favor or inhibit tumor growth20,21.
Disease-free survival was similar between patients 
with increased or decreased microvascular density. Stud-
ies reporting the highest microvascular density with the 
less favorable prognosis had evaluated primary tumors4. 
As increased microvascular density is associated with 
metastases, this might explain the unfavorable progres-
sion in these cases. Decreased radiosensitivity has been 
reported in primary tumors that had extreme microvas-
cular density, which might reflect regional modulation of 
neoangiogenesis22,23. In our study, multimodal treatment 
may have masked this correlation. Considering the great 
variation of microvascular density, also found in other 
studies, the sample was insufficient to establish significant 
relations with other clinical or histological variables24,25.
In conclusion, lymph node reactivity and microvas-
cular density in metastases from occult primary tumors are 
not correlated and have no relation to disease progression. 
In these patients, where the effect of the primary tumor 
on study parameters may be disregarded, it appears that 
lymph node metastases, one of the most relevant prog-
nostic factors in upper digestive tract and upper airway 
carcinomas, reflects clonal selection in which neoangiogen-
esis has minor importance. Furthermore, the classification 
we used may have masked correlations existing only in 
the metastatic microenvironment. Microvascular density 
reflects a form of interaction with adjacent tissues, essen-
tial for tumor growth, that may have regional or systemic 
effects. Obviously, the prognosis of an individual is multi-
factorial and microvascular density evaluates only a single 
moment within a fraction of the tumor. We were unable 
to clarify these functional aspects by the morphologic 
alterations we analyzed.
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